Vycor Medical(VYCO)
$0.040.00 (0.00%)
VYCO
Vycor Medical financials statements
$0.04
At close:0.00 (0.00%)
Vycor Medical (VYCO) Ratios
9 Followers
Vycor Medical Ratios
VYCO's free cash flow for Q3 2026 was $5.88K. For the 2026 fiscal year, VYCO's free cash flow was decreased by $-3.00 and operating cash flow was $5.89K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.12 | 0.15 | 0.14 | 0.14 | 0.15 |
| Quick Ratio | 0.08 | 0.11 | 0.09 | 0.07 | 0.09 |
| Cash Ratio | 0.02 | 0.02 | 0.01 | 0.01 | 0.03 |
| Solvency Ratio | -0.00 | -0.01 | -0.00 | -0.09 | -0.14 |
| Operating Cash Flow Ratio | -0.00 | 0.01 | 0.01 | -0.06 | 0.01 |
| Short-Term Operating Cash Flow Coverage | -0.02 | 0.07 | 0.04 | -0.27 | 0.03 |
| Net Current Asset Value | $ -4.35M | $ -3.99M | $ -3.73M | $ -3.28M | $ -2.84M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 1.21 | 1.06 | 1.12 | 1.16 | 0.93 |
| Debt-to-Equity Ratio | -0.25 | -0.29 | -0.33 | -0.34 | -0.36 |
| Debt-to-Capital Ratio | -0.33 | -0.40 | -0.50 | -0.51 | -0.57 |
| Long-Term Debt-to-Capital Ratio | -0.03 | -0.04 | -0.04 | -0.05 | -0.07 |
| Financial Leverage Ratio | -0.20 | -0.27 | -0.30 | -0.29 | -0.39 |
| Debt Service Coverage Ratio | 0.10 | 0.07 | 0.11 | -0.27 | -0.33 |
| Interest Coverage Ratio | 0.33 | -0.09 | 0.39 | -3.32 | -4.96 |
| Debt to Market Cap | 0.24 | 0.42 | 0.38 | 0.34 | 0.29 |
| Interest Debt Per Share | 0.03 | 0.04 | 0.04 | 0.03 | 0.03 |
| Net Debt to EBITDA | 9.54 | 15.72 | 10.45 | -3.89 | -3.08 |
| Profitability Margins | |||||
| Gross Profit Margin | 80.58% | 89.50% | 90.08% | 88.50% | 90.33% |
| EBIT Margin | 1.79% | -0.21% | 2.74% | -25.14% | -23.00% |
| EBITDA Margin | 5.18% | 3.81% | 6.90% | -20.12% | -18.09% |
| Operating Profit Margin | 1.82% | -0.58% | 2.75% | -25.06% | -31.30% |
| Pretax Profit Margin | -3.77% | -6.73% | -4.32% | -32.68% | -29.31% |
| Net Profit Margin | -3.89% | -6.75% | -4.77% | -33.19% | -37.58% |
| Continuous Operations Profit Margin | -3.77% | -6.73% | -4.32% | -32.68% | -29.31% |
| Net Income Per EBT | 103.19% | 100.23% | 110.48% | 101.55% | 128.22% |
| EBT Per EBIT | -207.05% | 1169.50% | -156.95% | 130.40% | 93.64% |
| Return on Assets (ROA) | -8.72% | -10.74% | -7.02% | -47.19% | -55.96% |
| Return on Equity (ROE) | 1.77% | 2.91% | 2.10% | 13.80% | 21.85% |
| Return on Capital Employed (ROCE) | -0.86% | 0.26% | -1.30% | 10.97% | 19.69% |
| Return on Invested Capital (ROIC) | -1.10% | 0.35% | -1.81% | 15.74% | 29.44% |
| Return on Tangible Assets | -8.72% | -10.74% | -8.33% | -49.41% | -61.60% |
| Earnings Yield | -1.79% | -4.66% | -2.77% | -14.22% | -18.03% |
| Efficiency Ratios | |||||
| Receivables Turnover | 8.51 | 6.48 | 6.79 | 7.83 | 11.05 |
| Payables Turnover | 4.27 | 1.13 | 1.23 | 0.70 | 0.59 |
| Inventory Turnover | 2.27 | 0.75 | 0.62 | 0.57 | 0.65 |
| Fixed Asset Turnover | 9.85 | 5.36 | 3.63 | 3.64 | 3.15 |
| Asset Turnover | 2.24 | 1.59 | 1.47 | 1.42 | 1.49 |
| Working Capital Turnover Ratio | -0.46 | -0.44 | -0.44 | -0.42 | -0.56 |
| Cash Conversion Cycle | 117.98 | 219.60 | 346.75 | 173.34 | -21.68 |
| Days of Sales Outstanding | 42.88 | 56.33 | 53.79 | 46.62 | 33.04 |
| Days of Inventory Outstanding | 160.60 | 486.18 | 589.60 | 645.88 | 562.21 |
| Days of Payables Outstanding | 85.50 | 322.90 | 296.64 | 519.16 | 616.93 |
| Operating Cycle | 203.48 | 542.50 | 643.39 | 692.50 | 595.25 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| Free Cash Flow Per Share | -0.00 | 0.00 | 0.00 | -0.01 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | -0.04 | 0.18 | 3.14 | -78.06 | 0.56 |
| Capital Expenditure Coverage Ratio | -2.58 | 14.32 | 3.14 | -78.06 | 0.56 |
| Operating Cash Flow Coverage Ratio | -0.01 | 0.06 | 0.03 | -0.22 | 0.02 |
| Operating Cash Flow to Sales Ratio | -0.01 | 0.04 | 0.02 | -0.18 | 0.02 |
| Free Cash Flow Yield | -0.46% | 2.43% | 0.80% | -7.70% | -0.59% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -10.17 | -21.21 | -36.12 | -7.03 | -5.55 |
| Price-to-Sales (P/S) Ratio | 2.17 | 1.45 | 1.72 | 2.33 | 2.08 |
| Price-to-Book (P/B) Ratio | -0.99 | -0.62 | -0.76 | -0.97 | -1.21 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -216.00 | 41.17 | 125.57 | -12.98 | -170.73 |
| Price-to-Operating Cash Flow Ratio | -299.76 | 38.30 | 85.53 | -13.15 | 135.87 |
| Price-to-Earnings Growth (PEG) Ratio | -0.04 | 0.29 | 6.60 | 0.25 | 0.11 |
| Enterprise Value Multiple | 51.38 | 53.75 | 35.44 | -15.49 | -14.60 |
| Enterprise Value | 4.96M | 3.25M | 3.57M | 3.81M | 3.68M |
| EV to EBITDA | 51.38 | 53.75 | 35.44 | -15.49 | -14.60 |
| EV to Sales | 2.66 | 2.05 | 2.44 | 3.12 | 2.64 |
| EV to Free Cash Flow | -265.29 | 58.19 | 178.11 | -17.34 | -216.41 |
| EV to Operating Cash Flow | -368.16 | 54.13 | 121.30 | -17.56 | 172.22 |
| Tangible Book Value Per Share | -0.12 | -0.11 | -0.11 | -0.09 | -0.08 |
| Shareholders’ Equity Per Share | -0.12 | -0.11 | -0.10 | -0.09 | -0.08 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.06 | 0.05 | 0.04 | 0.04 | 0.05 |
| Net Income Per Share | -0.00 | -0.00 | -0.00 | -0.01 | -0.02 |
| Tax Burden | 1.03 | 1.00 | 1.10 | 1.02 | 1.28 |
| Interest Burden | -2.10 | 31.71 | -1.58 | 1.30 | 1.27 |
| Research & Development to Revenue | 0.01 | 0.01 | 0.02 | 0.00 | 0.01 |
| SG&A to Revenue | 0.78 | 0.85 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.03 | 0.02 | 0.01 | 0.15 | 0.24 |
| Income Quality | 0.19 | -0.56 | -0.42 | 0.54 | -0.05 |
Currency in USD

